- Home
- NRGV vs RAPP Comparison
NRGV vs RAPP Comparison
Compare NRGV & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- RAPP
- Stock Information
- Founded
- NRGV 2017
- RAPP 2022
- Country
- NRGV United States
- RAPP United States
- Employees
- NRGV N/A
- RAPP N/A
- Industry
- NRGV Industrial Machinery/Components
- RAPP
- Sector
- NRGV Miscellaneous
- RAPP
- Exchange
- NRGV Nasdaq
- RAPP Nasdaq
- Market Cap
- NRGV 514.7M
- RAPP 439.4M
- IPO Year
- NRGV N/A
- RAPP 2024
- Fundamental
- Price
- NRGV $3.32
- RAPP $26.59
- Analyst Decision
- NRGV Buy
- RAPP Strong Buy
- Analyst Count
- NRGV 3
- RAPP 4
- Target Price
- NRGV $1.58
- RAPP $37.00
- AVG Volume (30 Days)
- NRGV 3.7M
- RAPP 1.1M
- Earning Date
- NRGV 11-11-2025
- RAPP 11-06-2025
- Dividend Yield
- NRGV N/A
- RAPP N/A
- EPS Growth
- NRGV N/A
- RAPP N/A
- EPS
- NRGV N/A
- RAPP N/A
- Revenue
- NRGV $51,716,000.00
- RAPP N/A
- Revenue This Year
- NRGV $314.58
- RAPP N/A
- Revenue Next Year
- NRGV $39.00
- RAPP N/A
- P/E Ratio
- NRGV N/A
- RAPP N/A
- Revenue Growth
- NRGV N/A
- RAPP N/A
- 52 Week Low
- NRGV $0.60
- RAPP $6.43
- 52 Week High
- NRGV $3.79
- RAPP $42.27
- Technical
- Relative Strength Index (RSI)
- NRGV 75.98
- RAPP 55.67
- Support Level
- NRGV $2.69
- RAPP $26.05
- Resistance Level
- NRGV $3.27
- RAPP $30.67
- Average True Range (ATR)
- NRGV 0.38
- RAPP 2.04
- MACD
- NRGV -0.00
- RAPP -0.34
- Stochastic Oscillator
- NRGV 68.60
- RAPP 32.21
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.